Dual targeted human beta defensin for improving chemotherapy
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA183353
- Recipient
-
Sci-Engi-Medco Solutions, Inc. UEI QFW6NVACLNU3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $264,958
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $40,000 | |
| Original award | $224,958 |
Quick answers
Who received award R43CA183353?
R43CA183353 was awarded to Sci-Engi-Medco Solutions, Inc. by National Institutes of Health (Department of Health and Human Services) on September 24, 2014.
How much is award R43CA183353 worth?
$264,958 has been obligated on R43CA183353.
Which agency awarded R43CA183353?
National Institutes of Health (Department of Health and Human Services) awarded R43CA183353, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award